Datroway(DatopotamabDeruxtecan-dlnk) Side Effects

This section summarizes the adverse reactions associated with DATROWAY treatment.

Adverse Reactions

The most common adverse reactions (≥20%) include stomatitis, nausea, fatigue, decreased leukocytes, decreased calcium, alopecia, decreased lymphocytes, decreased hemoglobin, constipation, decreased neutrophils, dry eye, vomiting, increased ALT, keratitis, increased AST, and increased alkaline phosphatase. Serious risks include interstitial lung disease/pneumonitis, which can be fatal, ocular adverse reactions like keratitis and dry eye, and severe stomatitis. Permanent discontinuation may be necessary for Grade 3 or 4 events.

DatopotamabDeruxtecan-dlnk(Datroway)
Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved